Patrick Urban

2.3k citations
28 papers · 1.8k · 2 hit papers · h-index 14

Impact in

    • Lung Cancer Treatments and Mutations
    • Advanced Breast Cancer Therapies
    • Brain Metastases and Treatment
    • Lung Cancer Diagnosis and Treatment
    • Breast Cancer Treatment Studies
    • Cancer Genomics and Diagnostics

Papers in

Patrick Urban

27 papers receiving 1.8k citations

Patrick Urban's Hit Papers

Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial 2017 · 470 citations
4700+3+6Years since publication100200300400

Peers

Patrick Urban
Comparison fields: 5 of 77
  • Pulmonary and Respiratory Medicine 763
  • Cancer Research 315
  • Oncology 232
  • Molecular Biology 484
  • Otorhinolaryngology 14
Replace Mirko Marabese with:
Mirko Marabese Italy
Jozien Helleman Netherlands
Yunqian Pan United States
Maurizia Mello Grand Italy
Anh G. Hoang United States
Jose Juarez United States
Paul R. Gavine China
Aejaz Nasir United States
Chiara Lazzari Italy
Qingfu Zeng China
Patrick Urban relative to Mirko Marabese Italy Mirko Marabese's profile →
Citations per field
00.5×1.5×2.2×
Mirko Marabese · 1×
Citations per year

Countries citing papers authored by Patrick Urban

Since Specialization
Citations

This map shows the geographic impact of Patrick Urban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Urban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Urban more than expected).

Fields of papers citing papers by Patrick Urban

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Urban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Urban. The network helps show where Patrick Urban may publish in the future.

Co-authors

The 25 scholars most cited alongside Patrick Urban, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Patrick Urban Line = papers co-authored together Patrick Urban links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial
Hit paper breakdown →
2017470
2
Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Hit paper breakdown →
2017460
3 2016208
4 2016160
5 201795
6 200658
7 200554
8 200654
9 200754
10 201753
11 201629
12 201117
13 201517
14 200616
15 19968
16 20218
17
PIK3CA Status in Circulating Tumor DNA Predicts Efficacy of Buparlisib Plus Fulvestrant in Postmenopausal Women With Endocrine-resistant HR+/HER2- Advanced Breast Cancer: First Results From the Randomized, Phase III BELLE-2 Trial
20157
18 20116
19 20116
20 20196

About Patrick Urban

Patrick Urban is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Pharmacology and Hematology, having authored 28 papers that have together received 1.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (5 papers), Breast Cancer Treatment Studies (5 papers), HER2/EGFR in Cancer Research (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Advanced Breast Cancer Therapies (4 papers), Platelet Disorders and Treatments (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (763 citations), Cancer Research (315 citations), Oncology (232 citations), Molecular Biology (484 citations) and Otorhinolaryngology (14 citations). Patrick Urban has collaborated with scholars based in Switzerland, United States and Spain. Frequent co-authors include Cristian Massacesi, Emmanuelle di Tomaso, Enriqueta Felip, Alice Tsang Shaw, Vincent Vuaroqueaux, Katsuyuki Kiura, Oliver Pascal Gautschi, Stéphanie Deudon, Urs Eppenberger and Serenella Eppenberger‐Castori. Their work appears in journals such as Breast Cancer Research, Annals of Oncology, Cancer Chemotherapy and Pharmacology, The Lancet Oncology and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact